The bone-renal axis in early chronic kidney disease: an emerging paradigm.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  2008-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ndt/gfn260PMID 18469306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin D

  2016cited by this paper
• Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.

  2008cited by this paper
• Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients.

  2008cited by this paper
• A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.

  2007cited by this paper
• Emerging role of fibroblast growth factor 23 in a bone–kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization

  2007cited by this paper
• Correction for Berndt et al., Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption

  2007cited by this paper
• Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption

  2007cited by this paper
• Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.

  2007cited by this paper
• The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis.

  2007cited by this paper
• Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.

  2007cited by this paper
• Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro.

  2007cited by this paper
• PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Role of Fibroblast Growth Factor 23 in Phosphate Homeostasis and Pathogenesis of Disordered Mineral Metabolism in Chronic Kidney Disease

  2007cited by this paper
• A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.

  2007cited by this paper
• Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community.

  2007cited by this paper
• Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3).

  2007cited by this paper
• PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Expanding Role for Vitamin D in Chronic Kidney Disease: Importance of Blood 25‐OH‐D Levels and Extra‐Renal 1α‐Hydroxylase in the Classical and Nonclassical Actions of 1α,25‐Dihydroxyvitamin D3

  2007cited by this paper
• Regulation of fibroblast growth factor-23 in chronic kidney disease.

  2007cited by this paper
• The parathyroid is a target organ for FGF23 in rats.

  2007cited by this paper
• Mineralized tissue cells are a principal source of FGF23.

  2007cited by this paper
• Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice.

  2007cited by this paper
• FGF23 Concentrations Vary With Disease Status in Autosomal Dominant Hypophosphatemic Rickets

  2007cited by this paper
• Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.

  2007cited by this paper
• Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.

  2006cited by this paper
• Klotho converts canonical FGF receptor into a specific receptor for FGF23

  2006cited by this paper
• Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients

  2006cited by this paper
• Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats.

  2006cited by this paper
• Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D

  2006cited by this paper
• Early growth response-1 in cardiovascular pathobiology.

  2006cited by this paper
• The phosphatonins and the regulation of phosphate homeostasis.

  2006cited by this paper
• Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

  2006cited by this paper
• Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men.

  2006cited by this paper
• Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes.

  2005cited by this paper
• Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

  2005influential reference
• Acute regulation of parathyroid hormone by dietary phosphate.

  2005cited by this paper
• Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.

  2005cited by this paper
• A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis.

  2005cited by this paper
• Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

  2004cited by this paper
• Vitamin D Insufficiency and Deficiency in Chronic Kidney Disease

  2004cited by this paper
• Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure.

  2004cited by this paper
• FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

  2004cited by this paper
• FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.

  2003cited by this paper
• Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats.

  2003cited by this paper
• Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

  2003cited by this paper
• FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate.

  2001cited by this paper
• Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure.

  1999cited by this paper
• Pathogenic, clinical, and therapeutic aspects of secondary hyperparathyroidism in chronic renal failure.

  1998cited by this paper
• Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study.

  1996cited by this paper
• Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease.

  1993cited by this paper
• Subfractions in uremic plasma ultrafiltrate inhibit calcitriol metabolism.

  1991cited by this paper
• Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.

  1984cited by this paper
• Metabolic acidosis suppresses 25-hydroxyvitamin in D3-1alpha-hydroxylase in the rat kidney. Distinct site and mechanism of action.

  1982cited by this paper
• Metabolic Acidosis Suppresses 25-Hydroxyvitamin D3-1α-Hydroxylase in the Rat Kidney: DISTINCT SITE AND MECHANISM OF ACTION

  1982cited by this paper
• Vitamin D: The calcium homeostatic steroid hormone

  1979cited by this paper
• On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis".

  1974cited by this paper
• On the pathogenesis of the uremic state--an exposition of the trade-off hypothesis.

  1972cited by this paper
• Control of phosphate excretion in uremic man.

  1968cited by this paper
• The control of phosphate excretion in uremia.

  1966cited by this paper
• Vitamin D

  1928cited by this paper

• Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation

  2024cites this paper
• The Relationship between Fibroblast Growth Factor-23, Insulin-Like Growth Factor-1, Bone Mineral Density, Insulin Resistance, and Hyperandrogenemia in Polycystic Ovary Syndrome

  2022cites this paper
• A Single-Center Study of Chronic Kidney Disease and Dietary Phosphate Restriction

  2022cites this paper
• Skeletal manifestations in end-stage renal disease patients and relation to FGF23 and Klotho

  2020cites this paper
• [Potential application of fibroblast growth factor 23-klotho axis in chronic kidney disease].

  2019cites this paper
• Chronic Kidney Disease-Mineral and Bone Disorder, Vitamin D Deficiency, and Secondary Hyperparathyroidism

  2019cites this paper
• Serum FGF-23 levels in predialysis chronic kidney disease are not associated with 25-OH D vitamin levels

  2018cites this paper
• Low Vitamin D Levels in Children with Fractures: a Comparative Cohort Study

  2015cites this paper
• Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy

  2015cites this paper
• Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBDs): What the Endocrinologist Needs to Know.

  2014cites this paper
• Impact of vitamin D on immune function: lessons learned from genome-wide analysis

  2014cites this paper
• [Mineral and bone disorders in renal transplantation].

  2013cites this paper
• [Bone mineral density and adequacy of dietary pattern of patients with chronic kidney disease in hemodialysis].

  2013cites this paper
• CHRONIC KIDNEY DISEASE MINERAL AND BONE DISORDERS (CKD-MBD) WHAT THE ENDOCRINOLOGIST NEEDS TO KNOW Running title: CKD-MBD and Endocrinologists

  2013cites this paper
• Bone Morphology and Mechanical Properties in Murine Models of Chronic Kidney Disease

  2013cites this paper
• FGF23 production by osteocytes

  2013cites this paper
• Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25‐dihydroxyvitamin D in human monocytes

  2013cites this paper
• Mineral and Bone Disorders in Chronic Kidney Disease

  2013cites this paper
• Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.

  2012cites this paper
• The consequences of chronic kidney disease on bone metabolism and growth in children.

  2012cites this paper
• Phosphorus and Nutrition in Chronic Kidney Disease

  2012cites this paper
• Implications for nutrition practice in the mineral-bone disorder of chronic kidney disease.

  2011cites this paper
• [Clinical and biochemical characteristics of predialysis patients in terms of 25 hydroxy vitamin D levels].

  2011influential citation
• [FGF23 and Klotho: the new cornerstones of phosphate/calcium metabolism].

  2011cites this paper
• FGF 23 and Klotho : The new cornerstones of phosphate / calcium metabolism

  2011cites this paper
• Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease.

  2010cites this paper
• Fibroblast growth factor (FGF)‐23 and fetuin‐A in calcified carotid atheroma

  2010cites this paper
• Commentary on "Acute parathyroid hormone increase by oral peptones administration after Roux-En-Y gastric bypass surgery in obese subjects: role of phosphate in the rapid control of parathyroid hormone release".

  2010cites this paper
• Optimizing bone health in chronic kidney disease.

  2010cites this paper
• The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease.

  2010cites this paper
• Acute parathyroid hormone increase by oral peptones administration after roux-en-Y gastric bypass surgery in obese subjects: role of phosphate in the rapid control of parathyroid hormone release.

  2010cites this paper
• Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

  2009cites this paper
• Dietary and Pharmacological Control of Calcium and Phosphate Metabolism in Dialysis Patients

  2009cites this paper
• Evaluation of the Role of FGF23 in Mineral Metabolism

  2009cites this paper
• FGF-23 in dialysis patients: ready for prime time?

  2008cites this paper